Literature DB >> 32576581

NONO Is a Negative Regulator of SOX2 Promoter.

Shanshan Liang1,2,3, Hidehisa Takahashi4,5, Tetsuro Hirose6, Yasuhiro Kuramitsu7, Shigetsugu Hatakeyama4, Hironori Yoshiyama2, Ruoyu Wang1, Jun-Ichi Hamada8,7, Hisashi Iizasa9,3.   

Abstract

BACKGROUND/AIM: Sex determining region Y (SRY)-box 2 (SOX2) is a transcription factor essential for the maintenance of proliferation and self-renewal of cancer stem cells and is associated with breast cancer initiation. Regulation of cancer stem cell plasticity by SOX2 requires both positive and negative SOX2 transcription factors, but the negative regulator is still largely unknown.
MATERIALS AND METHODS: SOX2 promoter-binding proteins were identified by liquid chromatography-mass spectrometry/mass spectrometry, luciferase assay, and chromatin immunoprecipitation. The effects of one such transcription factor on SOX2 expression was investigated by knockdown and overexpression experiments.
RESULTS: Non-POU domain-containing octamer-binding protein (NONO) (also known as 54-kDa nuclear RNA-binding protein, P54NRB) was identified as a SOX2 promoter-binding protein and a negative regulator of SOX2 expression. Its activity was controlled by its coiled-coil domain and the C-terminal domain.
CONCLUSION: These results suggest that NONO acts as a key regulator of SOX2 transcription through the repression of SOX2 promoter activity in breast cancer cells. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  SOX2; breast cancer; cancer stem cell; negative regulator; transcription factor

Mesh:

Substances:

Year:  2020        PMID: 32576581      PMCID: PMC7367599          DOI: 10.21873/cgp.20195

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  25 in total

1.  Glucocorticoid induction of occludin expression and endothelial barrier requires transcription factor p54 NONO.

Authors:  Jason M Keil; Xuwen Liu; David A Antonetti
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-06-12       Impact factor: 4.799

2.  PSF is a novel corepressor that mediates its effect through Sin3A and the DNA binding domain of nuclear hormone receptors.

Authors:  M Mathur; P W Tucker; H H Samuels
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

3.  Structure of the heterodimer of human NONO and paraspeckle protein component 1 and analysis of its role in subnuclear body formation.

Authors:  Daniel M Passon; Mihwa Lee; Oliver Rackham; Will A Stanley; Agata Sadowska; Aleksandra Filipovska; Archa H Fox; Charles S Bond
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-13       Impact factor: 11.205

Review 4.  The role of SOX family members in solid tumours and metastasis.

Authors:  Daniela Grimm; Johann Bauer; Petra Wise; Marcus Krüger; Ulf Simonsen; Markus Wehland; Manfred Infanger; Thomas J Corydon
Journal:  Semin Cancer Biol       Date:  2019-03-23       Impact factor: 15.707

5.  MENepsilon/beta noncoding RNAs are essential for structural integrity of nuclear paraspeckles.

Authors:  Yasnory T F Sasaki; Takashi Ideue; Miho Sano; Toutai Mituyama; Tetsuro Hirose
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

6.  Paraspeckle protein p54nrb links Sox9-mediated transcription with RNA processing during chondrogenesis in mice.

Authors:  Kenji Hata; Riko Nishimura; Shuji Muramatsu; Akio Matsuda; Takuma Matsubara; Katsuhiko Amano; Fumiyo Ikeda; Vincent R Harley; Toshiyuki Yoneda
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

7.  Identification of a novel repressor element in the cyclo-oxygenase-2 promoter and its nuclear binding protein.

Authors:  Xiaomin Yang; Ling Lin; Xiongfei Zhang; Yong Ji; Jinghuan Lv; Yunxia Zhu; Yongmei Yin; Yujie Sun; Xiao Han
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-06-01       Impact factor: 2.557

8.  NONO ubiquitination is mediated by FBW7 and GSK3 β via a degron lost upon chromosomal rearrangement in cancer.

Authors:  Luigi Alfano; Antonella Caporaso; Angela Altieri; Caterina Costa; Iris M Forte; Carmelina A Iannuzzi; Daniela Barone; Luca Esposito; Antonio Giordano; Francesca Pentimalli
Journal:  J Cell Physiol       Date:  2017-12-29       Impact factor: 6.384

9.  Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma.

Authors:  Claudia Lengerke; Tanja Fehm; Ralf Kurth; Hans Neubauer; Veit Scheble; Friederike Müller; Friederike Schneider; Karen Petersen; Diethelm Wallwiener; Lothar Kanz; Falko Fend; Sven Perner; Petra M Bareiss; Annette Staebler
Journal:  BMC Cancer       Date:  2011-01-28       Impact factor: 4.430

10.  Immunodetection of nmt55/p54nrb isoforms in human breast cancer.

Authors:  M Pavao; Y H Huang; L J Hafer; R B Moreland; A M Traish
Journal:  BMC Cancer       Date:  2001-10-29       Impact factor: 4.430

View more
  1 in total

1.  Establishment and characterization of a new spontaneously immortalized ER-/PR-/HER2+ human breast cancer cell line, DHSF-BR16.

Authors:  Stefania Nobili; Antonella Mannini; Astrid Parenti; Chiara Raggi; Andrea Lapucci; Giovanna Chiorino; Sara Paccosi; Paola Di Gennaro; Vania Vezzosi; Paolo Romagnoli; Tommaso Susini; Marcella Coronnello
Journal:  Sci Rep       Date:  2021-04-16       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.